Targeted lipid nanoparticles for treating central nervous system injuries
AssigneeWisconsin Alumni Research Foundation
InventorsDaniel Hellenbrand, Jacobus Burger, William Murphy, Amgad Hanna
Life of this patent
Estimating the term…
Abstract
The present invention provides lipid nanoparticles that comprise a therapeutic agent and have an astrocyte targeting peptide linked to their surface. Suppressor RNAs that restrict transgene expression to the central nervous system or to astrocytes, in particular, are also provided. Methods of using the lipid nanoparticles and suppressor RNAs in combination of therapeutic mRNAs to treat a central nervous system injury in a subject are also provided.
Claims21
A lipid nanoparticle comprising a therapeutic agent and an astrocyte targeting peptide, wherein the astrocyte targeting peptide is on the surface of the lipid nanoparticle.
A suppressor mRNA comprising a nucleotide sequence encoding a repressor protein and comprises at least one copy of an astrocyte-expressed miRNA target site in a 5′ untranslated region (UTR) and/or a 3′ UTR of the suppressor mRNA.
A method of treating a central nervous system (CNS) injury in a subject, the method comprising:
- administering a lipid nanoparticle comprising a therapeutic agent or therapeutic protein to the subject, wherein the lipid nanoparticle is delivered to the CNS injury.
Dependencies are inferred from the claim text.